Grant: JPIAMR Final Conference Travel Awards

Antimicrobial resistance (AMR) is a growing global health threat, making it harder to treat infections and increasing the risk of disease spread. To better track and respond to AMR in the environment, the TEXAS consortium is developing new technologies that can quickly and accurately detect antibiotic-resistant bacteria and genes. These include a digital droplet PCR system and a biochip, both designed to provide fast, cost-effective, and high-throughput testing. Once fully developed, these tools could be connected to online monitoring systems, helping healthcare facilities and environmental agencies keep a close watch on AMR trends. At the same time, we are working on PHES-ODM, a data model that will help different organizations collect and share AMR-related information in a standard way. To make sure AMR surveillance is both effective and reliable, we are also developing PHES-EF, a framework that helps decide which AMR markers should be tracked and how to measure the quality of surveillance efforts. We will soon bring together global experts to refine this framework through a Delphi consensus process. To support these efforts, we are conducting a living review of scientific research on AMR surveillance, using artificial intelligence to continuously scan and update findings. By combining cutting-edge detection tools, improved data-sharing methods, and real- time research updates, our work aims to provide trusted, standardized, and globally applicable solutions for reducing the impact of AMR.